Management Of Hirsutism: A Review on Pharmaceutical Approaches Based on Pathophysiology

In Females, Hirsutism describes excessive growth of coarse terminal hairs in the androgen-sensitive body parts. 5 to 10 percent of women of reproductive age are typically affected. The purpose of the review is to describe the cause and the different treatment in the case of hirsutism. Hirsutism is believed to have the largest impact on the health-related quality of life of patients, followed by body mass index, irregular menstruation, and infertility. To evaluate the types of hairs and pathogenesis, signs and symptoms and causes of hirsutism. The Ferriman-Gallwey score can be used to measure and evaluate women with hirsutism. In this review, the article anatomy of the hair follicle and phases of the hair growth cycle, androgens and their physiological role in hair growth is outlined. The history of a woman and physical examination play a crucial role especially in assessing the excess hair development. This paper has addressed systemic and topical therapy in the light of modern pharmaceutics with emphasis on novel approaches to molecular therapeutics in which siRNA and Antisense Oligonucleotides like approaches, safety, regulatory and translational concerns in future use.